The efficacy of vildagliptin on type 2 diabetic patients with basal-bolus insulin therapy in the short-term hospitalization (single-center, randomized, open-label, controlled study).

The efficacy of vildagliptin on type 2 diabetic patients with basal-bolus insulin therapy in the short-term hospitalization (single-center, randomized, open-label, controlled study). - The efficacy of vildagliptin on type 2 diabetic patients with basal-bolus insulin therapy in the short-term hospitalization.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011851

Enrollment

Registered

2013-09-24

Start date

2012-08-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

insulin alone group From admission, adjust the insulin dose to keep blood glucose of before each meal less than 120mg/dl without vildagliptin administration. insulin plus vildagliptin group From adm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetic patients who were admitted for diabetic control to Nippon Medical School Chiba-Hokusoh hospital

Exclusion criteria

Exclusion criteria: The subjects were excluded, if they were treated with insulin, DPP-4I or GLP-1 receptor agonist, have a history or evidence of liver or endocrine disease, recent myocardial infarction, cerebral vascular disease, heart failure, infectious disease, pregnancy or any carcinoma.

Design outcomes

Primary

Measure	Time frame
The daily profile of plasma glucose and serum lipid at discherge.	—

Secondary

Measure	Time frame
the required dose of insulin infusion to maintain the blood glucose normal.	—

Countries

Japan

Contacts

Public ContactFumitaka Okajima

Nippon Medical School, Chiba-Hokusoh Hospital Division of Endocrinology, Department of Medicine

okaji@nms.ac.jp0476-99-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026